Guardant Health and National Cancer Center East Japan Announce Liquid Biopsy Arm of Lung Cancer Trial

March 12, 2018

Responsive image

REDWOOD CITY, Calif., March 12, 2018 /PRNewswire/ — The Guardant360® assay, the leading comprehensive liquid biopsy, will be used as the sole liquid biopsy in LC-SCRUM-Japan, a nationwide genomic screening network run by the National Cancer Center Hospital East (NCCE) Kashiwa, Japan to…

Category: Precious Metals